Brazil's ANVISA thinks both big and small on GMP regulatory changes
This article was originally published in Clinica
Executive Summary
Brazil�s medical devices regulatory authority, ANVISA, is not overlooking the needs of smaller device manufacturers as it moves to simplify and align its regulatory processes with those of established major countries.